PL2632550T3 - Sposoby i kompozycja do leczenia biegunki związanej z HIV - Google Patents

Sposoby i kompozycja do leczenia biegunki związanej z HIV

Info

Publication number
PL2632550T3
PL2632550T3 PL11837249T PL11837249T PL2632550T3 PL 2632550 T3 PL2632550 T3 PL 2632550T3 PL 11837249 T PL11837249 T PL 11837249T PL 11837249 T PL11837249 T PL 11837249T PL 2632550 T3 PL2632550 T3 PL 2632550T3
Authority
PL
Poland
Prior art keywords
composition
methods
treating hiv
associated diarrhea
hiv associated
Prior art date
Application number
PL11837249T
Other languages
English (en)
Inventor
William Forbes
Enoch Bortey
Steven King
Pravin Chaturvedi
Original Assignee
Napo Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45994461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2632550(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Napo Pharmaceuticals Inc filed Critical Napo Pharmaceuticals Inc
Publication of PL2632550T3 publication Critical patent/PL2632550T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL11837249T 2010-10-31 2011-10-31 Sposoby i kompozycja do leczenia biegunki związanej z HIV PL2632550T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US40862210P 2010-10-31 2010-10-31
US40933510P 2010-11-02 2010-11-02
US41624910P 2010-11-22 2010-11-22
US201161434379P 2011-01-19 2011-01-19
EP11837249.9A EP2632550B1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea
PCT/US2011/058549 WO2012058664A1 (en) 2010-10-31 2011-10-31 Methods and compositions for treating hiv-associated diarrhea

Publications (1)

Publication Number Publication Date
PL2632550T3 true PL2632550T3 (pl) 2017-10-31

Family

ID=45994461

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11837249T PL2632550T3 (pl) 2010-10-31 2011-10-31 Sposoby i kompozycja do leczenia biegunki związanej z HIV

Country Status (20)

Country Link
US (4) US8962680B2 (pl)
EP (1) EP2632550B1 (pl)
JP (2) JP6063385B2 (pl)
CN (2) CN103370101A (pl)
AU (1) AU2011320155B2 (pl)
BR (1) BR112013010774A2 (pl)
CA (1) CA2816416C (pl)
DK (1) DK2632550T3 (pl)
EC (1) ECSP13012650A (pl)
ES (1) ES2635435T3 (pl)
HK (1) HK1249036A1 (pl)
HU (1) HUE035393T2 (pl)
MX (1) MX348184B (pl)
PE (1) PE20140036A1 (pl)
PH (1) PH12013500857A1 (pl)
PL (1) PL2632550T3 (pl)
PT (1) PT2632550T (pl)
RU (1) RU2597746C2 (pl)
WO (1) WO2012058664A1 (pl)
ZA (1) ZA201303136B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007248183B2 (en) * 2006-05-01 2013-08-01 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
US20070254050A1 (en) 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
JP2009535419A (ja) 2006-05-01 2009-10-01 ナポ ファーマシューティカルズ インク. 便秘型過敏性腸症候群の治療方法
US8962680B2 (en) 2010-10-31 2015-02-24 Salix Pharmaceuticals, Ltd. Methods and compositions for treating HIV-associated diarrhea
MX2015007065A (es) * 2012-12-07 2017-03-01 Napo Pharmaceuticals Inc Metodo y composiciones para tratar diarrea asociada con vih.
US11389424B2 (en) 2017-03-09 2022-07-19 Napo Pharmaceuticals, Inc. Methods and compositions for treating chemotherapy-induced diarrhea
JOP20190276A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
JOP20190275A1 (ar) 2017-05-31 2019-11-27 Napo Pharmaceuticals Inc طرق وتركيبات لعلاج اضطراب إسهال خِلقي
US11216742B2 (en) 2019-03-04 2022-01-04 Iocurrents, Inc. Data compression and communication using machine learning
CA3182864A1 (en) * 2020-06-19 2021-12-23 Lisa A. CONTE Methods and compositions for treating chemotherapy-induced diarrhea
WO2022115481A1 (en) * 2020-11-24 2022-06-02 Napo Pharmaceuticals, Inc. Methods and compositions for treating post-acute infection gastrointestinal disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5211944A (en) 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same
CA2269078C (en) 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
WO2000047062A2 (en) 1999-02-01 2000-08-17 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer dietary supplements and methods for preparing same
US20040071793A1 (en) 2002-10-05 2004-04-15 Bobrowski Paul J. Oral rehydration methods and compositions
WO2005074575A2 (en) * 2004-01-30 2005-08-18 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
JP2008546790A (ja) * 2005-06-22 2008-12-25 ユニバーシティー オブ マサチューセッツ Hiv−1プロテアーゼ阻害剤
EP1962829A1 (en) 2005-12-15 2008-09-03 Bayer HealthCare AG Diaryl ureas for treating virus infections
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
JP2009535419A (ja) 2006-05-01 2009-10-01 ナポ ファーマシューティカルズ インク. 便秘型過敏性腸症候群の治療方法
AU2007248183B2 (en) 2006-05-01 2013-08-01 Napo Pharmaceuticals, Inc. Compositions and methods for treating or preventing inflammatory bowel disease, familial adenomatous polyposis and colon cancer
WO2010021681A2 (en) 2008-08-18 2010-02-25 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US7928115B2 (en) 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
PH12012500557A1 (en) 2009-08-26 2012-10-22 Glenmark Pharmaceuticals Ltd Method for producing proanthocyanidin polymer compositions for pharmaceutical formulations
JP2013506716A (ja) * 2009-10-06 2013-02-28 ザ レゲンツ オブ ジ ユニヴァーシティ オブ カリフォルニア クロフェレマーなどのプロアントシアニジンオリゴマーを用いて疾患を治療する方法
US20110087530A1 (en) 2009-10-09 2011-04-14 Visa U.S.A. Inc. Systems and Methods to Provide Loyalty Programs
US8962680B2 (en) 2010-10-31 2015-02-24 Salix Pharmaceuticals, Ltd. Methods and compositions for treating HIV-associated diarrhea
BR112013018688B1 (pt) 2011-01-27 2021-08-24 Napo Pharmaceuticals, Inc Método de produção de uma composição polimérica de proantocianidina
RU2014124981A (ru) 2011-12-22 2016-02-10 Гленмарк Фармасьютикалс Лимитед Неэнтеросолюбильная фармацевтическая композиция, содержащая крофелемер
MX2015007065A (es) 2012-12-07 2017-03-01 Napo Pharmaceuticals Inc Metodo y composiciones para tratar diarrea asociada con vih.

Also Published As

Publication number Publication date
JP6063385B2 (ja) 2017-01-18
ECSP13012650A (es) 2013-10-31
US20120184605A1 (en) 2012-07-19
JP2017019806A (ja) 2017-01-26
BR112013010774A2 (pt) 2017-03-21
WO2012058664A1 (en) 2012-05-03
EP2632550A4 (en) 2014-04-23
JP2013540826A (ja) 2013-11-07
HK1249036A1 (zh) 2018-10-26
EP2632550B1 (en) 2017-05-03
CN107595836A (zh) 2018-01-19
ES2635435T3 (es) 2017-10-03
MX348184B (es) 2017-06-02
US8962680B2 (en) 2015-02-24
RU2013123794A (ru) 2014-12-10
RU2597746C2 (ru) 2016-09-20
CN103370101A (zh) 2013-10-23
US20150190367A1 (en) 2015-07-09
US20120107370A1 (en) 2012-05-03
PH12013500857A1 (en) 2018-01-17
US9585868B2 (en) 2017-03-07
CA2816416A1 (en) 2012-05-03
PE20140036A1 (es) 2014-01-31
PT2632550T (pt) 2017-08-02
ZA201303136B (en) 2016-01-27
AU2011320155A1 (en) 2013-05-09
US20140294903A1 (en) 2014-10-02
JP6310971B2 (ja) 2018-04-11
AU2011320155B2 (en) 2016-02-25
DK2632550T3 (en) 2017-08-07
EP2632550A1 (en) 2013-09-04
CA2816416C (en) 2020-02-11
HUE035393T2 (en) 2018-05-02
MX2013004873A (es) 2013-08-21

Similar Documents

Publication Publication Date Title
PL2632550T3 (pl) Sposoby i kompozycja do leczenia biegunki związanej z HIV
BR112013010725A2 (pt) método, e, composição
IL253870A0 (en) Certain amino-pyrimidines, their assemblies, and methods of using them
IL238416A0 (en) Preparations and methods for the treatment of diseases caused by protein pathology
PL2976946T3 (pl) Kompozycje cyklodekstryny, wyroby i sposoby
PL2884999T3 (pl) Sposób i kompozycje do immunoterapii komórkowej
BR112013008723A2 (pt) artigo, método, e, composição de revestimento
IL229072A0 (en) 1,3-oxazines as bace1 and/or bace2 inhibitors
PL2734049T3 (pl) Kompozycje probiotyczne i sposoby
IL222465A0 (en) Certain amino-pyridazines, compositions thereof, and methods for their use
PL2569260T3 (pl) Kompozycja powlekająca, sposób i wyrób
BR112013025814A2 (pt) composição e processo
BR112014010450A2 (pt) composição e método
BR112012027165A2 (pt) composição e artigo
EP2575825A4 (en) COMPOSITIONS AND METHODS FOR TREATING DEPRESSION
LT2552484T (lt) Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
BR112013022306A2 (pt) método, e, composição
IL232648A0 (en) Preparations and methods for treating glioma
EP2881444A4 (en) Water-repellent and oil-repellent composition and articles therewith
EP2722366A4 (en) CURABLE COMPOSITION
BR112013019224A2 (pt) composição, e metodo
EP2735581A4 (en) COMPOSITION AND POLYMER
BR112012029669A2 (pt) composição e método
BR112014010860A2 (pt) composição e método